Daniel S. Loeb, CEO and Founder of investment advisor Third Point LLC, and his wife, Margaret Munzer Loeb, recently made a $15 million gift to establish the Ronald M. Loeb Center for Alzheimer’s Disease in memory of Daniel’s father. The Center’s mission is to advance research and clinical care for patients with Alzheimer’s disease through discoveries in genomics, neurobiology, stem cell engineering, and other disciplines.
The Loeb Center will be led by Alison Goate, PhD, a highly regarded neuropsychiatric researcher and molecular geneticist at Icahn School of Medicine at Mount Sinai, who will work in concert with three renowned faculty members: Mary Sano, PhD, Associate Dean for Clinical Research, and Professor of Psychiatry; Sam Gandy, MD, PhD, Mount Sinai Professor in Alzheimer’s Research, Professor of Neurology and Psychiatry, and Associate Director, Mount Sinai Alzheimer’s Disease Research Center; and Eric Schadt, PhD, Jean C. and James W. Crystal Professor of Genomics, Chair, Genetics and Genomic Sciences, and Director, Icahn Institute for Genomics and Multiscale Biology.
“When my father was sick, I learned how painful this disease is for those afflicted and their families,” says Mr. Loeb. “It is my hope that this Center will bring together the best in the field to find the breakthrough we so urgently need.”
Kenneth L. Davis, MD, Chief Executive Officer and President of the Mount Sinai Health System, and a groundbreaking researcher in Alzheimer’s disease, says, “We are deeply grateful for the Loeb family’s immense generosity and unique vision. There has been a revolution in the way we think about Alzheimer’s disease, and that revolution has brought us to the threshold of major breakthroughs, which we will vigorously pursue at the Ronald M. Loeb Center.”